MAPT and Alzheimer disease: Since the in vitro dephosphorylation of p-tau with protein phosphatase 2A inhibits tau oligomerization [60], TEMT’s ability to dephosphorylate p-tau accomplishes this same action, presumably preventing or disaggregating p-tau oligomer formation in the brains of this study’s AD subjects.